PDB25 COST-EFFECTIVENESS OF DETEMIR VERSUS NPH FOR TYPE 1 DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A BELGIUM SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OFTHREE CLINICAL TRIALS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64973-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64973-X/fulltext
Title :
PDB25 COST-EFFECTIVENESS OF DETEMIR VERSUS NPH FOR TYPE 1 DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A BELGIUM SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OFTHREE CLINICAL TRIALS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64973-X&doi=10.1016/S1098-3015(10)64973-X
First page :
Section Title :
Open access? :
No
Section Order :
132